More than 200 advocates call on governors to retain telehealth flexibilities

More than 200 top healthcare groups and public companies are asking state governors to retain and expand state licensure exemptions facilitating access to telehealth services throughout the public health emergency, according to a recently published letter.

During the pandemic, many governors waived certain licensure requirements granting providers the flexibility to treat patients across state lines. The move provided “unprecedented” benefits, but many states have recently allowed COVID-19 emergency declarations to expire, stripping access to valuable telehealth services.

This has proven particularly costly for immunocompromised patients and those who require specialty care. In many cases, these individuals are driving across state lines to take telehealth appointments from their car, the Alliance for Connected Care, ALS Association and National Organization for Rare Disorders, who led the letter, noted.

“Given the urgency of the times as more states consider rolling back flexibilities enacted at the start of the pandemic, states must act now to ensure patients can access the care they need where they reside and when they need it, without having to choose between canceling an appointment or traveling long distances and risking potential exposure to the COVID-19 virus for an in-person visit,” the organizations wrote Oct. 28. 

A laundry list of medical groups, hospitals and associations signed the letter, including Amazon, Duke University Health System, the Healthcare Information & Management Systems Society (HIMSS) and the Mayo Clinic.

Read the entire document here.

 

 

Related Telehealth Content:

Patient demand for telemedicine remains strong

Telehealth claims surged in 2020

AMA pushes for equity in telehealth

Walmart acquires telehealth provider MeMD

Google takes $100M plunge into telehealth

Telehealth demand starts to soften

HHS awards $55 million to expand virtual healthcare access

Telehealth visits have declined since the onset of COVID-19

Find more telemedicine stories

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup